{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:40:07Z","timestamp":1748972407658,"version":"3.41.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>The opioid crisis is a profound public health crisis in the United States. It has significantly increased morbidity and mortality in our nation. There are many contributing factors to the opioid crisis, including a strong national and international interest to treat pain as effectively as possible. To combat this crisis, numerous strategies have been implemented over the past few years at the legislative, health system, and patient levels. As a result of these efforts, for the first time since 1999, drug overdose deaths in the United States decreased from 2017 to 2018, when deaths involving all opioids, prescription opioids, and heroin decreased by 2%, 13.5%, and 4.1%, respectively. To continue to curb the opioid crisis, it is imperative to optimize pain control through multidisciplinary and multimodal approaches and to adhere to opioid prescribing guidelines from regulatory and professional organizations to minimize risks for opioid misuse and abuse. Urine drug testing is an important means to assist with opioid monitoring and safe opioid prescribing. There are challenges when ordering urine drug tests, collecting specimens, and interpreting test results. Inaccurate interpretations of laboratory results can have significantly negative impacts on patients care and life. There is a critical need for prescriber education by laboratory experts in the use of drug testing and interpretation of results. To interpret test results correctly and make safe prescribing decisions, it is very important for prescribers\/providers to consult clinical toxicologists, laboratory directors, and reporting staff. This interaction is vital and provides excellence of care for patients. This review aims to provide information concerning the opioid crisis in the United States and summarizes the challenges ordering and interpreting opioid-related laboratory testing as well as pertinent guidelines and recommendations.<\/jats:p>","DOI":"10.1097\/ftd.0000000000000840","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T22:32:43Z","timestamp":1606257163000},"page":"6-13","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Physician Perspective and Challenges Ordering\/Interpreting Laboratory Tests Related to the Opioid Crisis in America"],"prefix":"10.1097","volume":"43","author":[{"given":"Xiaoying","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Pain Management Center, University of Virginia Health System, Charlottesville, Virginia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy C.","family":"Bratanow","sequence":"additional","affiliation":[{"name":"Midwest Comprehensive Pain Care, Milwaukee, Wisconsin."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006-2015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers\u2014United States, 2002-2004 and 2008-2010","volume":"132","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013-2017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"R4-20250603","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2017","volume":"329","author":"Hedegaard","year":"2018","journal-title":"NCHS Data Brief."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002-2012","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am J Public Health."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.2018.0158","article-title":"The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states","volume":"319","author":"Mokdad","year":"2018","journal-title":"JAMA."},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/ajhp\/zxy089","article-title":"The opioid crisis: origins, trends, policies, and the roles of pharmacists","volume":"76","author":"Chisholm-Burns","year":"2019","journal-title":"Am J Health Syst Pharm."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health."},{"key":"R10-20250603","first-page":"1151","article-title":"Treating chronic pain","volume":"55","author":"Montauk","year":"1997","journal-title":"Am Fam Physician."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1071\/HC12258","article-title":"From ladder to platform: a new concept for pain management","volume":"4","author":"Leung","year":"2012","journal-title":"J Prim Health Care."},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/JPR.S244173","article-title":"The modified WHO analgesic ladder: is it appropriate for chronic non-cancer pain?","volume":"13","author":"Yang","year":"2020","journal-title":"J Pain Res."},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bja.2017.11.098","article-title":"Pain as the fifth vital sign and dependence on the numerical pain scale is being abandoned in the US: why?","volume":"120","author":"Levy","year":"2018","journal-title":"Br J Anaesth."},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.2106\/JBJS.19.00437","article-title":"Ethics of opioid prescriber regulations: physicians, patients, and pain","volume":"101","author":"Lajam","year":"2019","journal-title":"J Bone Joint Surg Am."},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.suc.2019.06.002","article-title":"Optimizing pain control during the opioid epidemic","volume":"99","author":"Harbaugh","year":"2019","journal-title":"Surg Clin North Am."},{"issue":"3 suppl","key":"R19-20250603","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician."},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med."},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain."},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1213\/ANE.0000000000002403","article-title":"The US opioid crisis: current federal and state legal issues","volume":"125","author":"Soelberg","year":"2017","journal-title":"Anesth Analg."},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/pm\/pnz159","article-title":"Opioid prescribing laws are not associated with short-term declines in prescription opioid distribution","volume":"21","author":"Davis","year":"2020","journal-title":"Pain Med."},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"107754","DOI":"10.1016\/j.drugalcdep.2019.107754","article-title":"The association between pain clinic laws and prescription opioid exposures: new evidence from multi-state comparisons","volume":"206","author":"Liang","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"R29-20250603","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2018","volume":"356","author":"Hedegaard","year":"2020","journal-title":"NCHS Data Brief."},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths - United States, 2017-2018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"R31-20250603","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drugalcdep.2018.09.022","article-title":"Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review","volume":"194","author":"Davis","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11606-016-3810-3","article-title":"Association between initial opioid prescribing patterns and subsequent long-term use among opioid-na\u00efve patients: a statewide retrospective cohort study","volume":"32","author":"Deyo","year":"2017","journal-title":"J Gen Intern Med."},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.annemergmed.2017.08.042","article-title":"Opioid prescribing for opioid-naive patients in emergency departments and other settings: characteristics of prescriptions and association with long-term use","volume":"71","author":"Jeffery","year":"2018","journal-title":"Ann Emerg Med."},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13012-018-0719-8","article-title":"Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing","volume":"13","author":"McGinty","year":"2018","journal-title":"Implement Sci."},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2105\/AJPH.2015.302953","article-title":"Opioid overdose deaths and Florida's crackdown on pill mills","volume":"106","author":"Kennedy-Hendricks","year":"2016","journal-title":"Am J Public Health."},{"key":"R37-20250603","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/BOT.0000000000001430","article-title":"Orthopaedic Trauma Association Musculoskeletal Pain Task Force. Clinical practice guidelines for pain management in acute musculoskeletal injury","volume":"33","author":"Hsu","year":"2019","journal-title":"J Orthop Trauma."},{"key":"R38-20250603","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/ACO.0000000000000796","article-title":"Pharmacological strategies in multimodal analgesia for adults scheduled for ambulatory surgery","volume":"32","author":"Richeb\u00e9","year":"2019","journal-title":"Curr Opin Anaesthesiol."},{"key":"R39-20250603","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2500United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA."},{"key":"R40-20250603","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.mayocp.2015.04.010","article-title":"Opioid analgesics","volume":"90","author":"Jamison","year":"2015","journal-title":"Mayo Clin Proc."},{"key":"R41-20250603","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain."},{"key":"R42-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep."},{"key":"R43-20250603","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5055\/jom.2007.0022","article-title":"Family physicians' proficiency in urine drug test interpretation","volume":"3","author":"Reisfield","year":"2007","journal-title":"J Opioid Manag."},{"key":"R44-20250603","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5055\/jom.2007.0044","article-title":"Urine drug test interpretation: what do physicians know?","volume":"3","author":"Reisfield","year":"2007","journal-title":"J Opioid Manag."},{"key":"R45-20250603","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11606-012-2165-7","article-title":"They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain","volume":"27","author":"Starrels","year":"2012","journal-title":"J Gen Intern Med."},{"key":"R46-20250603","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1373\/jalm.2017.024299","article-title":"Reflections of two pain medicine clinicians in the era of the opioid crisis","volume":"2","author":"Hamill-Ruth","year":"2018","journal-title":"J Appl Lab Med."},{"key":"R48-20250603","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3810\/pgm.2013.07.2684","article-title":"Risks, management, and monitoring of combination opioid, benzodiazepines, and\/or alcohol use","volume":"125","author":"Gudin","year":"2013","journal-title":"Postgrad Med."},{"key":"R50-20250603","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/jalm.2017.023341","article-title":"Executive summary: American Association of Clinical Chemistry laboratory medicine practice guideline\u2014using clinical laboratory tests to monitor drug therapy in pain management patients","volume":"2","author":"Jannetto","year":"2018","journal-title":"J Appl Lab Med."},{"key":"R52-20250603","doi-asserted-by":"crossref","first-page":"123","DOI":"10.36076\/ppj.2011\/14\/123","article-title":"Urine drug testing in chronic pain","volume":"14","author":"Christo","year":"2011","journal-title":"Pain Physician."},{"key":"R53-20250603","first-page":"SE1","article-title":"Immunoassay-based drug tests are inadequately sensitive for medication compliance monitoring in patients treated for chronic pain","volume":"20","author":"Snyder","year":"2017","journal-title":"Pain Physician."},{"issue":"2 suppl","key":"R54-20250603","first-page":"S5","article-title":"Opioids in the management of chronic non-cancer pain: an update of American society of the interventional pain physicians' (ASIPP) guidelines","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician."},{"key":"R55-20250603","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/pm\/pnx285","article-title":"Rational urine drug monitoring in patients receiving opioids for chronic pain: consensus recommendations","volume":"19","author":"Argoff","year":"2018","journal-title":"Pain Med."},{"key":"R57-20250603","first-page":"33","article-title":"Urine drug tests: ordering and interpreting results","volume":"99","author":"Kale","year":"2019","journal-title":"Am Fam Physician."},{"key":"R58-20250603","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.mayocp.2016.12.007","article-title":"Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens","volume":"92","author":"Moeller","year":"2017","journal-title":"Mayo Clin Proc."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:19:12Z","timestamp":1748971152000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000840","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"2020-08-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}